Stock Fundamentals

Company Information

Company Name
Immix Biopharma Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45258H1068
CIK: 0001873835
CUSIP: 45258H106
Currency: USD
Full Time Employees: 21
Phone: 310 651 8041
Fiscal Year End: December
IPO Date: Dec 16, 2021
Description:

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.

Address:

11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064

Directors & Officers

Name Title Year Born
Dr. Ilya Rachman M.B.A., M.D., Ph.D. Co-Founder, CEO, Chief Scientific Officer & Chairman 1973
Mr. Gabriel Morris B.A. President, CFO & Director 1987

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 10, 2025 Gabriel S Morris N/A Purchase 770.00 $6.58 $5.07K
Dec 10, 2025 Ilya M Rachman N/A Purchase 746.00 $6.67 $4.98K
Sep 17, 2025 Ilya M Rachman N/A Purchase 2.50K $2.02 $5.05K
Sep 16, 2025 Gabriel S Morris N/A Purchase 2.60K $1.97 $5.12K
Jun 18, 2025 Gabriel S Morris N/A Purchase 2.23K $2.28 $5.07K
Jun 18, 2025 Ilya M Rachman N/A Purchase 2.18K $2.29 $4.99K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
HHG PLC 4.80M Mar 31, 2026 8.83% $0.02 22.45%
Saturn V Capital Management LLC 3.69M Mar 31, 2026 6.79% $6.09 23.15%
Eventide Asset Management, LLC 2.55M Mar 31, 2026 4.68% $0.38 0.00%
Millennium Management LLC 1.75M Mar 31, 2026 3.22% $0.01 5.45%
Marshall Wace Asset Management Ltd 1.64M Mar 31, 2026 3.02% $0.01 -17.04%
Logos Global Management LP 1.23M Mar 31, 2026 2.25% $0.56 22.50%
Vanguard Group Inc 1.10M Dec 31, 2025 2.01% $0.00 50.08%
Bleichroeder LP 1.00M Mar 31, 2026 1.84% $1.57 0.00%
Franklin Resources Inc 969.07K Mar 31, 2026 1.78% $0.00 -1.16%
Velan Capital Investment Management LP 740.00K Mar 31, 2026 1.36% $4.22 2,014.29%
Blue Owl Capital Holdings LP 547.55K Mar 31, 2026 1.01% $1.34 -44.48%
Susquehanna International Group, LLP 471.39K Mar 31, 2026 0.87% $0.00 19.68%
BlackRock Inc 468.38K Mar 31, 2026 0.86% $0.00 259.58%
Geode Capital Management, LLC 463.38K Mar 31, 2026 0.85% $0.00 88.32%
T. Rowe Price Associates, Inc. 415.00K Mar 31, 2026 0.76% $0.00 0.00%
Great Point Partners LLC 350.00K Mar 31, 2026 0.64% $0.73 0.00%
Institute for Wealth Management, LLC 337.55K Mar 31, 2026 0.62% $0.33 0.00%
Burkehill Global Management, LP 294.12K Mar 31, 2026 0.54% $0.13 0.00%
KVP Capital Advisors, LP 230.42K Mar 31, 2026 0.42% $1.57 0.00%
J. Goldman & Co LP 228.09K Mar 31, 2026 0.42% $0.06 92.87%

Shares Statistics

Shares Outstanding: 71.19M
Shares Float: 40.34M
% Insiders: 1,749.70%
% Institutions: 3,891.60%
Short % Float: 7.65%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Eventide Healthcare & Life Sciences I 2.55M 4.68% ▲ 0.00% Dec 31, 2025
2 Vanguard Total Stock Mkt Idx Inv 1.29M 2.36% ▲ 0.00% Apr 30, 2026
3 Franklin Biotechnology Discv A(acc)USD 612.03K 1.12% ▲ 0.00% Apr 30, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 459.74K 0.84% ▲ 0.60% Apr 30, 2026
5 HR SICAV - Global Quant Equits - (GBP) A 416.59K 0.77% ▲ 0.00% Apr 30, 2026
6 Franklin Biotechnology Discovery A 357.03K 0.66% ▲ 0.00% Apr 30, 2026
7 Fidelity Extended Market Index 216.62K 0.40% ▲ 87.14% Mar 31, 2026
8 IMC US Ultra Micro Cap 147.14K 0.27% ▲ 0.00% Apr 30, 2026
9 Blackrock Extended Mkt Fund CF 106.94K 0.20% ▲ 0.00% Apr 30, 2026
10 BlackRock Extended Equity Market Fund K 91.06K 0.17% ▲ 63.85% Mar 31, 2026

Valuation Metrics

Enterprise Value: $568.25M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $595.50M
EBITDA: $-35.78M
Book Value: $1.59
Earnings/Share: $-0.92
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -38.97%
ROE (TTM): -74.46%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 10.01x 0.00x 0.11x N/A -0.01x
2024-12-31 2.33x 0.00x 0.42x N/A 0.00x
2023-12-31 5.32x 0.00x 0.19x N/A 0.00x
2022-12-31 11.70x 0.00x 0.12x -16,537.12x 0.00x
2021-12-31 90.01x 0.00x 0.01x -7.52x 0.00x
2020-12-31 0.10x -0.87x 9.77x -4.45x -9.08x
2019-12-31 0.20x -1.12x 4.87x -7.66x -4.87x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IMMX.US!